Cynthia H Y Fu,Guray Erus,Yong Fan,Mathilde Antoniades,Danilo Arnone,Stephen R Arnott,Taolin Chen,Ki Sueng Choi,Cherise Chin Fatt,Benicio N Frey,Vibe G Frokjaer,Melanie Ganz,Jose Garcia,Beata R Godlewska,Stefanie Hassel,Keith Ho,Andrew M McIntosh,Kun Qin,Susan Rotzinger,Matthew D Sacchet,Jonathan Savitz,Haochang Shou,Ashish Singh,Aleks Stolicyn,Irina Strigo,Stephen C Strother,Duygu Tosun,Teresa A Victor,Dongtao Wei,Toby Wise,Rachel D Woodham,Roland Zahn,Ian M Anderson,J F William Deakin,Boadie W Dunlop,Rebecca Elliott,Qiyong Gong,Ian H Gotlib,Catherine J Harmer,Sidney H Kennedy,Gitte M Knudsen,Helen S Mayberg,Martin P Paulus,Jiang Qiu,Madhukar H Trivedi,Heather C Whalley,Chao-Gan Yan,Allan H Young,Christos Davatzikos

Abstract:Background: Efforts to develop neuroimaging-based biomarkers in major depressive disorder (MDD), at the individual level, have been limited to date. As diagnostic criteria are currently symptom-based, MDD is conceptualized as a disorder rather than a disease with a known etiology; further, neural measures are often confounded by medication status and heterogeneous symptom states. Methods: We describe a consortium to quantify neuroanatomical and neurofunctional heterogeneity via the dimensions of novel multivariate coordinate system (COORDINATE-MDD). Utilizing imaging harmonization and machine learning methods in a large cohort of medication-free, deeply phenotyped MDD participants, patterns of brain alteration are defined in replicable and neurobiologically-based dimensions and offer the potential to predict treatment response at the individual level. International datasets are being shared from multi-ethnic community populations, first episode and recurrent MDD, which are medication-free, in a current depressive episode with prospective longitudinal treatment outcomes and in remission. Neuroimaging data consist of de-identified, individual, structural MRI and resting-state functional MRI with additional positron emission tomography (PET) data at specific sites. State-of-the-art analytic methods include automated image processing for extraction of anatomical and functional imaging variables, statistical harmonization of imaging variables to account for site and scanner variations, and semi-supervised machine learning methods that identify dominant patterns associated with MDD from neural structure and function in healthy participants. Results: We are applying an iterative process by defining the neural dimensions that characterise deeply phenotyped samples and then testing the dimensions in novel samples to assess specificity and reliability. Crucially, we aim to use machine learning methods to identify novel predictors of treatment response based on prospective longitudinal treatment outcome data, and we can externally validate the dimensions in fully independent sites. Conclusion: We describe the consortium, imaging protocols and analytics using preliminary results. Our findings thus far demonstrate how datasets across many sites can be harmonized and constructively pooled to enable execution of this large-scale project.

An empirical analysis of structural neuroimaging profiles in a staging model of depression

Identifying Subgroups of Major Depressive Disorder Using Brain Structural Covariance Networks and Mapping of Associated Clinical and Cognitive Variables

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

Twenty-Five Cohorts of Major Depressive Disorder in China: Evidence for Reduced But Not Enhanced Default Mode Network Functional Connectivity

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

Altered Resting-State Dynamic Functional Brain Networks in Major Depressive Disorder: Findings from the REST-meta-MDD Consortium

More Alike than Different: Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder across Neuroimaging Modalities

Frontostriatal salience network expansion in individuals in depression

Neurophysiological Stratification of Major Depressive Disorder by Distinct Trajectories

Identification of structural brain alterations in adolescents with depressive symptomatology

Severity of current depression and remission status are associated with structural connectome alterations in major depressive disorder

Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group

Structural and functional brain alterations in subthreshold depression: A multimodal coordinate‐based meta‐analysis

2177 – Neuroanatomical Changes Associated with Subthreshold Depression in Adolescents

Diagnostic Potential of Structural Neuroimaging for Depression from a Multi-Ethnic Community Sample.

Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder

Characterization of Major Depressive Disorder Using a Multiparametric Classification Approach Based on High Resolution Structural Images.

AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale

Expansion of a frontostriatal salience network in individuals with depression

A comprehensive hierarchical comparison of structural connectomes in Major Depressive Disorder cases v. controls in two large population samples

Neurobiologically Based Stratification of Recent- Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic Phenotypes